Top Page
China Reinsurance (Group) Corp. Class H
(Frankfurt:1508)
China Reinsurance (Group) Corp. Class H (1508) vs. S&P 500 (SPY)
China Reinsurance (Group) Corp. Class H Business Overview & Revenue Model
China Reinsurance (Group) Corp. Class H Financial Statement Overview
| Breakdown | ||||
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 94.96B | 167.41B | 163.95B | 168.10B | 142.58B | Gross Profit |
| 88.28B | 167.41B | 163.95B | 168.10B | 142.58B | EBIT |
| -6.68B | 4.89B | 8.82B | 8.38B | 8.52B | EBITDA |
| 171.29M | 1.85B | -1.65B | -1.30B | -1.05B | Net Income Common Stockholders |
| 5.65B | 1.87B | 5.95B | 5.71B | 6.05B |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 10.30B | 10.97B | 18.74B | 10.22B | 18.29B | Total Assets |
| 459.73B | 520.69B | 499.80B | 453.58B | 396.64B | Total Debt |
| 15.43B | 17.96B | 27.23B | 27.79B | 25.06B | Net Debt |
| 5.14B | 6.99B | 8.49B | 17.57B | 6.77B | Total Liabilities |
| 357.55B | 426.02B | 397.71B | 350.68B | 299.66B | Stockholders Equity |
| 93.25B | 86.02B | 92.71B | 93.03B | 87.14B |
| Cash Flow | Free Cash Flow | |||
| 15.86B | 11.31B | 9.12B | 32.34B | 14.70B | Operating Cash Flow |
| 16.29B | 11.71B | 9.56B | 33.24B | 16.88B | Investing Cash Flow |
| -14.83B | -6.80B | -15.57B | -47.34B | -14.57B | Financing Cash Flow |
| 999.20M | -12.20B | 14.01B | 7.96B | 3.97B |
China Reinsurance (Group) Corp. Class H Technical Analysis
China Reinsurance (Group) Corp. Class H Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | HK$331.42B | 9.50 | 13.15% | 5.27% | 3.52% | 26.44% | |
75 Outperform | HK$137.43B | 8.59 | 9.77% | 5.19% | -43.77% | ― | |
75 Outperform | $915.21B | 3.53 | 22.83% | 4.70% | 5.96% | 124.20% | |
72 Outperform | $926.38B | 6.69 | 5.29% | 11.71% | 37.04% | ||
70 Outperform | $278.25B | 4.50 | 16.47% | 3.93% | 11.99% | 54.60% | |
66 Neutral | €38.66B | 3.38 | 10.61% | 5.85% | 0.54% | 84.27% | |
64 Neutral | $12.64B | 9.74 | 8.05% | 17044.60% | 12.66% | -4.62% |
China Reinsurance (Group) Corp. Class H Corporate Events
China Reinsurance (Group) Corporation has released its solvency and financial indicators for the first quarter of 2025, showcasing a strong financial position with a core solvency adequacy ratio of 325% at the group level. The company’s subsidiaries also reported solid solvency ratios, indicating a stable financial foundation. The announcement highlights the company’s commitment to transparency and its ability to meet regulatory requirements, which is crucial for maintaining investor confidence and supporting its market positioning.
China Reinsurance (Group) Corporation announced the release of its annual reports, audit reports, and audited solvency statements for the year ended December 31, 2024, for its subsidiaries China Re P&C and China Re Life. The company has successfully issued capital supplementary bonds worth RMB4.0 billion and RMB5.0 billion in the National Interbank Bond Market. This disclosure is in compliance with relevant regulations and aims to enhance transparency and accountability, potentially strengthening the company’s market position and investor confidence.
China Reinsurance (Group) Corporation announced the unaudited financial data and solvency statement for its subsidiary, China Re P&C, for the first quarter of 2025. The company disclosed a comprehensive financial position with total assets amounting to RMB 147.53 billion. This disclosure is part of regulatory requirements following the issuance of capital supplementary bonds, reflecting the company’s commitment to transparency and compliance, potentially impacting its market positioning and stakeholder confidence.
China Reinsurance (Group) Corporation announced the unaudited financial data and solvency statement for its subsidiary, China Re Life, for the first quarter of 2025. The company successfully issued RMB5.0 billion in capital supplementary bonds, which necessitates regular disclosure of financial and solvency reports. This move is expected to strengthen China Re Life’s financial position and enhance transparency, potentially impacting its market standing and stakeholder confidence.
China Reinsurance (Group) Corporation announced its audited consolidated results for the year ended December 31, 2024, reporting a significant increase in net profit to RMB 11.08 billion from RMB 5.79 billion in 2023. The company has successfully implemented new international financial reporting standards, which contributed to improved financial performance and operational efficiency, reflecting positively on its market positioning and stakeholder confidence.
China Reinsurance (Group) Corporation has announced a final cash dividend of RMB 0.05 per share for the financial year ending December 31, 2024. The record date for the dividend is set for July 9, 2025, with payment scheduled for August 22, 2025. This announcement is part of the company’s ongoing commitment to return value to its shareholders, potentially enhancing its market position and investor confidence.
China Reinsurance (Group) Corporation has announced a board meeting scheduled for March 28, 2025, to consider and approve the annual results for the year ending December 31, 2024. The meeting will also discuss the potential payment of a final dividend and address any other business matters, which could impact the company’s financial strategy and stakeholder interests.
China Reinsurance (Group) Corporation announced the approval of Ms. Zhu Xiaoyun’s qualification as an executive director by the National Financial Regulatory Administration. Her term as an executive director and member of the risk management committee will begin on February 24, 2025, and continue until the end of the fifth session of the board. This appointment is significant for the company’s governance and strategic direction, potentially impacting its risk management practices and board dynamics.
China Reinsurance (Group) Corporation has announced the composition of its board of directors, which includes nine directors with various roles and functions. The board has established five specialized committees, indicating a structured approach to governance and oversight, which may enhance the company’s operational efficiency and strategic execution.
China Reinsurance (Group) Corporation has announced an expected increase in net profit attributable to its equity shareholders by approximately 80% to 100% for the year 2024, compared to 2023. This anticipated growth stems from the company’s strategic focus on expanding business scale, improving underwriting performance, and achieving growth in investment income, highlighting its strong operational capabilities and market positioning.
For the period from January 1 to January 31, 2025, China Reinsurance (Group) Corporation reported an aggregate primary premium income of approximately RMB6,628 million. This financial metric, prepared according to PRC Accounting Standards for Business Enterprises, has not been audited or reviewed by the company’s audit committee, indicating stakeholders should interpret the data cautiously.